炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 12月19日，药明康德收涨2.08%，收盘价为92.47元，发生10笔大宗交易，合计成交量300万股，成交金 额2.64亿元。 第1笔成交价格为87.85元，成交78.96万股，成交金额6,936.74万元，溢价率为-5.00%，买方营业部为机 构专用，卖方营业部为华泰证券股份有限公司上海分公司。 第6笔成交价格为87.85元，成交19.95万股，成交金额1,752.63万元，溢价率为-5.00%，买方营业部为瑞 银证券有限责任公司上海花园石桥路证券营业部，卖方营业部为华泰证券股份有限公司上海分公司。 第7笔成交价格为87.85元，成交16.49万股，成交金额1,448.31万元，溢价率为-5.00%，买方营业部为瑞 银证券有限责任公司上海花园石桥路证券营业部，卖方营业部为华泰证券股份有限公司上海分公司。 第8笔成交价格为87.85元，成交6.23万股，成交金额547.49万元，溢价率为-5.00%，买方营业部为瑞银 证券有限责任公司上海花园石桥路证券营业部，卖方营业部为华泰证券股份有限公司上海分公司。 第9笔成交价格为87.85元，成 ...

Group 1: Market Overview - The total trading amount for the Shanghai Stock Connect was 940.49 billion, while the Shenzhen Stock Connect reached 1,048.92 billion [2] - The top traded stocks on the Shanghai Stock Connect included Zhaoyi Innovation with 23.86 billion, followed by Sanfang Qianhe and Luoyang Copper with 16.87 billion and 15.55 billion respectively [3] - On the Shenzhen Stock Connect, the leading stock was Zhongji Xuchuang with 26.44 billion, followed by Sunshine Power and New Yisheng with 26.09 billion and 25.89 billion respectively [3] Group 2: Sector Performance - Sectors such as Hainan, dairy, and retail showed significant gains, while precious metals and semiconductors experienced declines [4] - The mechanical equipment sector led in net inflow of funds with 38.67 billion, followed by non-ferrous metals and transportation equipment with 35.32 billion and 31.28 billion respectively [5] - The electronic sector had the highest net outflow of funds at -57.70 billion, followed by semiconductors and pharmaceuticals with -30.20 billion and -17.73 billion respectively [6] Group 3: Individual Stock Activity - The top stocks with net inflow included Xue Ren Group with 13.84 billion, followed by N Youxun and Shanzi Gaoke with 13.69 billion and 10.55 billion respectively [7] - The stocks with the highest net outflow were Meinian Health at -9.05 billion, followed by Shenwei Electronics and C Muxi-U with -6.98 billion and -6.81 billion respectively [8] Group 4: ETF Trading - The top ETFs by trading amount included A500 ETF Huatai Baichuan with 133.655 billion, and Hong Kong Securities ETF with 104.353 billion, showing increases of 7.50% and 18.61% respectively [9] - The ETFs with the highest growth in trading amount compared to the previous trading day included Hengsheng Dividend Low Volatility ETF with 183.92% increase and Industrial Nonferrous ETF with 140.82% increase [10] Group 5: Futures Market - In the futures market, all four major index contracts (IH, IF, IC, IM) saw both long and short positions increase, with IF and IM contracts showing a higher number of short position increases [11] Group 6: Institutional and Retail Activity - Institutional activity showed a decrease compared to the previous day, with notable purchases in Aerospace Intelligence and Shanzi Gaoke, while significant sales were observed in Meinian Health and Xue Ren Group [12][13] - Retail investors were active, with significant buying in Xue Ren Group and Shanzi Gaoke, while selling was noted in Huaren Health and other stocks [14][15]

沪指12月19日上涨0.36%，申万所属行业中，今日上涨的有28个，涨幅居前的行业为商贸零售、综合， 涨幅分别为3.66%、2.22%。医药生物行业今日上涨1.27%。跌幅居前的行业为银行、电子、煤炭，跌幅 分别为0.44%、0.29%、0.29%。 资金面上看，两市主力资金全天净流入70.25亿元，今日有18个行业主力资金净流入，机械设备行业主 力资金净流入规模居首，该行业今日上涨1.18%，全天净流入资金38.84亿元，其次是汽车行业，日涨幅 为1.47%，净流入资金为35.17亿元。 主力资金净流出的行业有13个，电子行业主力资金净流出规模居首，全天净流出资金46.40亿元，其次 是医药生物行业，净流出资金为15.79亿元，净流出资金较多的还有银行、国防军工、交通运输等行 业。 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 603259 | 药明康德 | 2.08 | 1.88 | 40193.37 | | 000566 | 海南海药 | 10.03 | 11.37 | 16469.77 ...

中国经济网北京12月19日讯 药明康德(603259.SH)昨日晚间发布关于股东权益变动触及1%刻度的提 示性公告。 2025年11月26日至2025年12月17日，药明康德加权均价为91.477元。经计算，上述股东减持金额合 计约26.99亿元。 (责任编辑：田云绯) 2025年12月17日，公司收到信息披露义务人发出的通知，获知其于2025年11月26日至2025年12月17 日通过集中竞价和大宗交易方式合计减持公司股份29,508,754股，占公告日公司总股本的0.989%。信息 披露义务人及与实际控制人签署投票委托书的股东合计持有公司股份数从535,711,396股减少至 506,202,642股，持股比例从17.95%减少至16.97%，权益变动触及1%刻度。 公司实际控制人为Ge Li（李革）、张朝晖、刘晓钟。信息披露义务人G&C IV Hong Kong Limited、G&C V Limited、G&C VI Limited、G&C VII Limited、嘉兴厚锦投资合伙企业（有限合伙）、 嘉兴厚毅投资合伙企业（有限合伙）、嘉兴厚毓投资合伙企业（有限合伙）、嘉兴厚咨投资合伙企业 （有限合伙） ...

Core Viewpoint - The healthcare sector in mainland China has experienced a pullback due to the results of national medical insurance drug price negotiations and subsequent profit-taking, but the fundamentals remain unchanged, presenting a good entry opportunity for 2026 [1] Group 1: Industry Outlook - The trend of innovative drug licensing is expected to continue, with multiple potential targets and drug forms anticipated to bring new licensing opportunities next year [1] - Key global Phase III clinical data readings for these licensed assets will be crucial for market sentiment and warrant close attention [1] - Geopolitical concerns regarding China's pharmaceutical R&D outsourcing industry (CXO) have peaked, and a stable medical policy environment in China is expected to continue supporting innovation [1] Group 2: Market Recovery - A more moderate drug procurement policy is expected to drive a recovery in the medical device and diagnostics sectors [1] Group 3: Stock Preferences - The company prefers biotechnology and CXO stocks, with top picks including Innovent Biologics (01801), Kelun-Biotech (06990), WuXi AppTec H-shares (02359), WuXi AppTec A-shares (603259.SH), and WuXi Biologics (02268) [1] - The target price for Innovent Biologics has been slightly raised from HKD 110 to HKD 111, maintaining a "Buy" rating, while the target price for WuXi Biologics has increased from HKD 74 to HKD 82, also with a "Buy" rating [1]

Core Viewpoint - The report from JPMorgan indicates that despite a recent downturn in the mainland healthcare sector due to national medical insurance drug price negotiations and subsequent profit-taking, the fundamental outlook for the industry remains unchanged, presenting a good entry opportunity for 2026 [1] Group 1: Industry Outlook - The healthcare sector experienced a decline in September and October, but JPMorgan believes this weakness provides a favorable entry point for investors looking towards 2026 [1] - The trend of innovative drug licensing is expected to continue, with multiple potential targets and drug forms anticipated to bring new licensing opportunities in the coming year [1] - Geopolitical concerns regarding China's pharmaceutical research outsourcing industry (CXO) are believed to have peaked, and a stable medical policy environment is expected to support innovation [1] Group 2: Market Recovery - A more moderate approach to drug volume procurement is expected to drive a recovery in the medical device and diagnostics sectors [1] Group 3: Stock Preferences - JPMorgan favors biotechnology and CXO stocks, specifically highlighting Innovent Biologics, Kelun-Biotech, WuXi AppTec H-shares, WuXi AppTec A-shares, and WuXi Biologics as preferred picks [1] - The target price for Innovent Biologics has been slightly raised from HKD 110 to HKD 111, while WuXi Biologics' target price has increased from HKD 74 to HKD 82, with both stocks rated as "Overweight" [1]

Group 1 - The article discusses China's technological advancements, particularly in the development of extreme ultraviolet (EUV) lithography machines, which have been a focus of concern for Western nations [1] - It highlights that only Dutch company ASML currently produces EUV lithography machines, while China has made progress in deep ultraviolet (DUV) lithography machines, with official parameters announced for domestic DUV machines [1] - The Ministry of Commerce has approved some general license applications for rare earth exports, indicating a gradual easing of export controls as Chinese exporters meet basic requirements [2] Group 2 - The China Securities Regulatory Commission (CSRC) aims to steadily expand high-level institutional openness in the capital market, enhancing its attractiveness and inclusivity to better serve economic development [3] - The State Administration for Market Regulation emphasizes the need to address "involutionary" competition and promote a healthy market order that encourages fair competition and optimizes the business environment [2] Group 3 - Zhongwei Company is planning to acquire a controlling stake in Hangzhou Zhonggui Electronic Technology Co., with its stock suspended from trading starting December 19, 2025, for up to 10 trading days [3] - Guoao Technology's former actual controller was sentenced to six years in prison for manipulating the securities market, but the company’s operations remain normal and unaffected [5] - Haitian Flavor Industry has announced a shareholder return plan for 2025-2027, committing to a cash dividend ratio of no less than 80% of net profit [5] - China International Capital Corporation (CICC) will distribute a total cash dividend of 434 million yuan for the first half of 2025, with the record date set for December 26, 2025 [5] - Luyuan Pharmaceutical reported that its recent business operations are normal, with no significant changes in the internal and external operating environment [6] - Western Mining's subsidiary has obtained a mining license for a polymetallic mine, with significant resource estimates including 2.86 tons of gold [7] - Sichuan Road and Bridge announced that China Post Insurance has increased its stake to 5% through market purchases [8] - Hongda Electronics' associate company Jiangsu Zhanchin's application for listing on the ChiNext has been accepted, with the company holding a 13.79% stake [9] - WuXi AppTec reported that 18 shareholders collectively reduced their holdings by approximately 29.5 million shares between November 26 and December 17 [9]

Group 1: Company Announcements - Multiple A-share listed companies disclosed shareholding changes on December 18, with Dazhong Mining, Sichuan Road and Bridge, and Tibet Pharmaceutical announcing share increases [1][8] - Companies including Lidasin, WuXi AppTec, Feilong Co., Ruichen Environmental Protection, Lihu Lake Co., Junshi Biosciences, Yidong Electronics, Huahai Chengke, Boshuo Technology, Allianz Ruishi, and Dazhong Mining reported share reductions [1][8] Group 2: Macroeconomic and Market Analysis - Russian Foreign Ministry spokesperson Zakharova stated that the launch of the Hainan Free Trade Port is an innovative move that will lay the foundation for Hainan's successful development and expand business opportunities for both domestic and foreign individuals [2][9] - The establishment of the Hainan Free Trade Port and other pilot free trade zones is seen as an effective measure to promote foreign trade, improve trade structure, and achieve trade diversification [2][9] Group 3: Market Performance and Related Assets - U.S. stock indices closed higher on Thursday, with the Dow Jones up 0.14%, Nasdaq up 1.38%, and S&P 500 up 0.79% [3][10] - Notable performances in tech stocks included Amazon and Meta rising over 2%, while Tesla increased by over 3% [3][10] - The Nasdaq Golden Dragon China Index rose over 1%, with significant gains in stocks such as Canadian Solar up 6.07% and Zai Lab up 4.56% [3][10] Group 4: Commodity and Price Forecasts - Goldman Sachs predicts that by 2026, the average price of Brent crude oil and West Texas Intermediate crude oil will drop to $56 and $52 per barrel, respectively, and iron ore prices will decline by 15% to $88 per ton [3][10] - The firm maintains a forecast for copper prices to reach $15,000 by 2035 and recommends a long position in copper and a short position in aluminum [3][10] Group 5: Institutional Views and Market Analysis - Goldman Sachs holds an optimistic view on gold prices, predicting a 14% increase to $4,900 per ounce by December 2026, with potential upside risks to this forecast [4][11] Group 6: Funding and Liquidity Trends - Following the recent interest rate cuts by the Federal Reserve, several banks, including Jiangsu Bank and HSBC (China), have lowered their U.S. dollar deposit product rates [5][12] - Jiangsu Bank reported a decrease of 0.05 percentage points in its latest U.S. dollar deposit rates for 3-month, 6-month, and 1-year terms, which were previously 4.45%, 4.35%, and 4.25% respectively [5][12] Group 7: Regulatory Dynamics and Company Risk Events - European Central Bank officials indicated that the interest rate reduction cycle is likely over, with deposit rates expected to remain at 2% unless significant shocks occur [6][13] - ECB President Lagarde emphasized the uncertainty in the current economic environment, stating that no guidance could be provided and all options should be retained [6][13]

Company News - GuoDun Quantum's chairman, Lv Pin, unexpectedly passed away [7] - CICC announced a cash dividend of 434 million yuan for the first half of 2025, with the record date set for December 26 [8] - Haitian Flavoring announced that its cash dividend ratio will not be less than 80% annually for the next three years (2025-2027) [9] - Sichuan Road and Bridge announced that China Post Insurance has increased its stake to 5% [10] - Zhongwei Company announced plans to acquire Hangzhou Zhonggui's equity, leading to a stock suspension [11] - WuXi AppTec reported that 18 shareholders, including the third, fourth, and sixth largest, collectively reduced their holdings by 29.5 million shares between November 26 and December 17 [11] - Lida Xin announced that shareholder Li Chunhua reduced his stake by 1.56% between December 10 and December 17 [12] - Visionox plans to sign an investment cooperation agreement to advance the Hefei 8.6-generation AMOLED production line project, with a second-phase capital of 9.443 billion yuan [12] - Western Mining announced that its wholly-owned subsidiary, Geermu West Mining Resources, has obtained a mining license, with gold reserves of 2.86 tons [13] - Yidong Electronics announced that a related party reduced its holdings by 2.3463 million shares between December 10 and December 17 [14] - Shandong Highway plans to provision for a long-term equity investment impairment of approximately 690 million yuan in Dongxing Securities [15] - GuoAo Technology's former actual controller, Chen Chongjun, was sentenced to six years in prison for manipulating the securities market, with a fine of 4 million yuan [16] Industry News - The Hong Kong Stock Exchange is consulting market opinions on optimizing the framework for trading units, with potential adjustments affecting about 25% of issuers [5] - The Ministry of Commerce responded to the latest developments in export controls on rare earth-related items, indicating that some Chinese exporters have met the basic requirements for applying for general licenses [5] - The National Digital Exchange System Engineering Technology Research Center, in collaboration with China Mobile and China Unicom, has achieved breakthroughs in resource scheduling efficiency and reliability through a "multi-modal on-the-fly computing" model [5] - The scale of China's biomanufacturing industry has continued to grow, reaching a total scale of 1.1 trillion yuan, with biopharmaceutical product output accounting for over 70% of the global total [5] - Platinum has become a highly sought-after asset, with the price of pure platinum reaching 815 yuan per gram, and futures contracts seeing a significant increase of 5.32% on December 18 [6]

Industry News - The State Council issued opinions on cracking down on illegal tobacco activities, emphasizing strict regulation of e-cigarettes and severe penalties for illegal production, wholesale, transportation, and sales [2][7] - Wu Qing attended a meeting to discuss the capital market's 14th Five-Year Plan, focusing on risk prevention, strong regulation, and promoting high-quality development [6][7] - The Ministry of Commerce responded to the European Commission's investigations into Chinese companies, highlighting the discriminatory nature of these actions and affirming China's commitment to protecting its enterprises [2][7] Company News - GuoDun Quantum's chairman, Lv Pin, unexpectedly passed away [10] - China International Capital Corporation announced a cash dividend of 434 million yuan for the first half of 2025, with the record date set for December 26 [10] - Li Chunhua, a shareholder of Lida Xin, reduced his stake by 1.56% between December 10 and December 17 [10] - Visionox plans to sign an investment cooperation agreement to advance the Hefei 8.6-generation AMOLED production line project, with a capital requirement of 9.443 billion yuan [10] Investment Opportunities - Micron Technology reported a booming demand for High Bandwidth Memory (HBM), with a projected compound annual growth rate (CAGR) of approximately 40%, increasing from about $35 billion in 2025 to around $100 billion by 2028 [20] - The persistent demand for memory in AI computing highlights the critical role of HBM, as the need for memory capacity and bandwidth continues to grow significantly [20]